Patients non-eligible for transplant

Kwee Yong | ESH MM 2018 | Options for frontline treatment when new drugs are not available

L: Emglish

4th International Conference on Multiple Myeloma, European School of Haematology, 5–7 October, Mandelieu, France
Prof Kwee Yong talks about ongoing trials for newly diagnosed patients not eligible for autologous stem cell transplantation, and frontline treatment when new drugs are not available.

 

Download this article:

You can now download this article in Adobe PDF® format.

Download as PDF